KYORIN Pharmaceutical Co.,Ltd.

KYORIN Pharmaceutical Co., Ltd. researches, develops, manufactures, and sells ethical and generic drugs in Japan and internationally through its subsidiaries. Its product lineup includes Flutiform for asthma, Lyfuna for cough, Desalex as an antiallergic agent, Beova and Uritos KYORIN for overactive bladder, Lasvic as a quinolone synthetic antibacterial agent, Pentasa for ulcerative colitis and Crohn's disease, Nasonex and Mometasone KYORIN for allergic rhinitis, and Kipres as a leukotriene receptor antagonist for bronchial asthma and allergic rhinitis. The company also offers Mucodyne, GeneSoC, Rubysta, Milton, over-the-counter drugs, prescription medicines and quasi-drugs, diagnostics, and subcontracted drug manufacturing services. It has a development and commercialization agreement with Hyfe Inc. for digital therapeutics for chronic cough. Formerly known as KYORIN Holdings, Inc., the company was founded in 1923 and is headquartered in Tokyo, Japan.